aTyr Pharma (ATYR) Revenue & Revenue Breakdown
aTyr Pharma Revenue Highlights
Latest Revenue (Y)
$353.00K
Latest Revenue (Q)
$190.00K
aTyr Pharma Revenue by Period
aTyr Pharma Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $353.00K | -96.60% |
| 2022-12-31 | $10.39M | 100.00% |
| 2021-12-31 | - | -100.00% |
| 2020-12-31 | $10.46M | 2377.49% |
| 2019-12-31 | $422.00K | 100.00% |
| 2018-12-31 | - | 100.00% |
| 2017-12-31 | - | 100.00% |
| 2016-12-31 | - | - |
aTyr Pharma generated $353.00K in revenue during NA 2023, up -96.60% compared to the previous quarter, and up Infinity% compared to the same period a year ago.
aTyr Pharma Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2025-09-30 | $190.00K | 100.00% |
| 2025-06-30 | - | 100.00% |
| 2025-03-31 | - | 100.00% |
| 2024-12-31 | - | 100.00% |
| 2024-09-30 | - | 100.00% |
| 2024-06-30 | - | -100.00% |
| 2024-03-31 | $235.00K | 100.00% |
| 2023-12-31 | - | -100.00% |
| 2023-09-30 | $353.00K | 100.00% |
| 2023-06-30 | - | 100.00% |
| 2023-03-31 | - | -100.00% |
| 2022-12-31 | $10.39M | 100.00% |
| 2022-09-30 | - | 100.00% |
| 2022-06-30 | - | 100.00% |
| 2022-03-31 | - | 100.00% |
| 2021-12-31 | - | 100.00% |
| 2021-09-30 | - | 100.00% |
| 2021-06-30 | - | 100.00% |
| 2021-03-31 | - | -100.00% |
| 2020-12-31 | $2.05M | 1287.16% |
| 2020-09-30 | $148.00K | -21.69% |
| 2020-06-30 | $189.00K | -97.66% |
| 2020-03-31 | $8.06M | 5500.69% |
| 2019-12-31 | $144.00K | -21.74% |
| 2019-09-30 | $184.00K | 95.74% |
| 2019-06-30 | $94.00K | 100.00% |
| 2019-03-31 | - | 100.00% |
| 2018-12-31 | - | 100.00% |
| 2018-09-30 | - | 100.00% |
| 2018-06-30 | - | 100.00% |
| 2018-03-31 | - | 100.00% |
| 2017-12-31 | - | - |
aTyr Pharma generated $190.00K in revenue during Q3 2025, up 100.00% compared to the previous quarter, and up Infinity% compared to the same period a year ago.
aTyr Pharma Revenue Breakdown
aTyr Pharma Revenue Breakdown by Product
Quarterly Revenue by Product
| Product/Service | Sep 25 |
|---|---|
| Collaboration Revenue | $200.00K |
Latest
aTyr Pharma's latest quarterly revenue breakdown by segment (product or service), as of Sep 25: Collaboration Revenue (100.00%).
aTyr Pharma Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| CAMP | CAMP4 Therapeutics | $186.23M | $795.00K |
| DTIL | Precision BioSciences | $68.70M | $13.00K |
| MGX | Metagenomi | $44.76M | $8.66M |
| HYFT | MindWalk | $24.52M | $6.98M |
| ATYR | aTyr Pharma | $353.00K | $190.00K |
| ALXO | ALX Oncology | - | - |
| RPTX | Repare Therapeutics | - | - |
| QNCX | Quince Therapeutics | - | - |
| RLMD | Relmada Therapeutics | - | - |
| UNCY | Unicycive Therapeutics | - | - |
| ACRV | Acrivon Therapeutics | - | - |